UT Code § 26-41-102 (2021)
2021 Utah Code|Title 26 - Utah Health Code|Chapter 41 - Emergency Response for Life-threatening Conditions|Section 102 - Definitions.

 Effective 7/1/2020  26-41-102. Definitions.  As used in this chapter:  (1) "Anaphylaxis" means a potentially life-threatening hypersensitivity to a substance.   (a) Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.     (b) Causes of anaphylaxis may include insect sting, food allergy, drug reaction, and exercise.       (2) "Asthma action plan" means a written plan:   (a) developed with a school nurse, a student's parent or guardian, and the student's health care provider to help control the student's asthma; and     (b) signed by the student's:   (i) parent or guardian; and     (ii) health care provider.         (3) "Asthma emergency" means an episode of respiratory distress that may include symptoms such as wheezing, shortness of breath, coughing, chest tightness, or breathing difficulty.     (4) "Epinephrine auto-injector" means a portable, disposable drug delivery device that contains a measured, single dose of epinephrine that is used to treat a person suffering a potentially fatal anaphylactic reaction.     (5) "Health care provider" means an individual who is licensed as:   (a) a physician under Title 58, Chapter 67, Utah Medical Practice Act;     (b) a physician under Title 58, Chapter 68, Utah Osteopathic Medical Practice Act;     (c) an advanced practice registered nurse under Section 58-31b-302; or     (d) a physician assistant under Title 58, Chapter 70a, Utah Physician Assistant Act.       (6) "Pharmacist" means the same as that term is defined in Section 58-17b-102.     (7) "Pharmacy intern" means the same as that term is defined in Section 58-17b-102.     (8) "Physician" means the same as that term is defined in Section 58-67-102.     (9) "Qualified adult" means a person who:   (a) is 18 years of age or older; and     (b)   (i) for purposes of administering an epinephrine auto-injector, has successfully completed the training program established in Section 26-41-104; and     (ii) for purposes of administering stock albuterol, has successfully completed the training program established in Section 26-41-104.1.         (10) "Qualified epinephrine auto-injector entity":   (a) means a facility or organization that employs, contracts with, or has a similar relationship with a qualified adult who is likely to have contact with another person who may experience anaphylaxis; and     (b) includes:   (i) recreation camps;     (ii) an education facility, school, or university;     (iii) a day care facility;     (iv) youth sports leagues;     (v) amusement parks;     (vi) food establishments;     (vii) places of employment; and     (viii) recreation areas.         (11) "Qualified stock albuterol entity" means a public or private school that employs, contracts with, or has a similar relationship with a qualified adult who is likely to have contact with another person who may experience an asthma emergency.     (12) "Stock albuterol" means a prescription inhaled medication:   (a) used to treat asthma; and     (b) that may be delivered through a device, including:   (i) an inhaler; or     (ii) a nebulizer with a mouthpiece or mask.        Amended by Chapter 372, 2020 General Session